By Devika Patel
Knoxville, Tenn., Dec. 18 – Dechra Pharmaceuticals plc said it settled a private placement of senior notes in two multicurrency parts.
The €50 million note is due in seven years and the $100 million note is due in 10 years. This debt has a weighted average coupon of 2.8%.
Proceeds will be used to repay the company’s term loan facility.
Dechra is a veterinary pharmaceuticals and related products business based in Northwich, U.K.
| Issuer: | Dechra Pharmaceuticals plc
|
| Issue: | Senior notes
|
| Amount: | €50 million, $100 million
|
| Coupon: | 2.8% (weighted average)
|
| Pricing date: | Nov. 19
|
| Settlement date: | Dec. 18
|
| Distribution: | Private placement
|
|
|
| First tranche
|
| Amount: | €50 million
|
| Maturity: | Seven years
|
|
|
| Second tranche
|
| Amount: | $100 million
|
| Maturity: | 10 years
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
